Skip to main content
Erschienen in: Journal of Immigrant and Minority Health 3/2014

01.06.2014 | Original Paper

HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border

verfasst von: Jennifer Molokwu, Norma P. Fernandez, Charmaine Martin

Erschienen in: Journal of Immigrant and Minority Health | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Despite advances in prevention of cervical cancer in the US, women of Hispanic origin still bear an unequal burden in cervical cancer incidence, morbidity and mortality. Our objective was to determine the HPV vaccine knowledge and acceptability in a group of mostly Hispanic females. In this cross sectional survey, 62 % of participants heard of HPV; 34.9 % identified HPV as a cause of cervical cancer. 63 % of participants reported willingness to receive vaccine and 77 % were willing to vaccinate daughters. Those with previous abnormal PAPs were more likely to have heard of HPV and Vaccine. No other factors examined showed association with willingness to get vaccine or administer to daughters. Knowledge level remains low in this high risk population. Willingness to receive vaccine is high despite lack of access to care. Increased targeted community based education and vaccination programs may be useful in closing disparity in cervical cancer morbidity.
Literatur
1.
Zurück zum Zitat Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health. 2000;36(1):6–10.CrossRef Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health. 2000;36(1):6–10.CrossRef
2.
Zurück zum Zitat Kahn JA, Hillard PA. Human papillomavirus and cervical cytology in adolescents. Adolesc Med Clin. 2004;15(2):301–321, ix. Kahn JA, Hillard PA. Human papillomavirus and cervical cytology in adolescents. Adolesc Med Clin. 2004;15(2):301–321, ix.
3.
Zurück zum Zitat Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.PubMedCrossRef Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.PubMedCrossRef
4.
Zurück zum Zitat Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995;33(8):2058–63.PubMedCentralPubMed Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995;33(8):2058–63.PubMedCentralPubMed
5.
Zurück zum Zitat WHO/ICO Information Center on HPV and Cervical Cancer (HPV Information Center). Human papillomavirus and related cancers in the world. Summary Report 2010. www.who.int/hpvcentre. Accessed 11 Oct 2012. WHO/ICO Information Center on HPV and Cervical Cancer (HPV Information Center). Human papillomavirus and related cancers in the world. Summary Report 2010. www.​who.​int/​hpvcentre. Accessed 11 Oct 2012.
7.
Zurück zum Zitat Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.PubMedCrossRef Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.PubMedCrossRef
8.
Zurück zum Zitat Risser DR, Mokry B, Bowcock C, Miller EA, Williams MA, Magid R, Garcia R. Cervical Cancer in Texas, 2010. Austin, TX: Texas Cancer Registry, Texas Department of State Health Services; Cancer Prevention Research Institute of Texas; 2010. Risser DR, Mokry B, Bowcock C, Miller EA, Williams MA, Magid R, Garcia R. Cervical Cancer in Texas, 2010. Austin, TX: Texas Cancer Registry, Texas Department of State Health Services; Cancer Prevention Research Institute of Texas; 2010.
9.
Zurück zum Zitat de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.PubMedCrossRef de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.PubMedCrossRef
10.
Zurück zum Zitat Szarewski A, Poppe WA, Skinner SR, et al. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer. 2012;131(1):106–16.PubMedCrossRef Szarewski A, Poppe WA, Skinner SR, et al. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer. 2012;131(1):106–16.PubMedCrossRef
11.
Zurück zum Zitat Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.PubMedCentralPubMedCrossRef Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.PubMedCrossRef Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.PubMedCrossRef
13.
Zurück zum Zitat Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45(5):430–7.PubMedCrossRef Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45(5):430–7.PubMedCrossRef
14.
Zurück zum Zitat Shen-Gunther J, Shank J, Ta V. Gardasil™ HPV vaccination HPV vaccination: surveillance of vaccine usage and adherence in a military population. Gynecol Oncol. 2011;123:272.PubMedCrossRef Shen-Gunther J, Shank J, Ta V. Gardasil™ HPV vaccination HPV vaccination: surveillance of vaccine usage and adherence in a military population. Gynecol Oncol. 2011;123:272.PubMedCrossRef
15.
Zurück zum Zitat Manhart LE, Burgess-Hull AJ, Fleming CB, Bailey JA, Haggerty KP, Catalano RF. HPV vaccination among a community sample of young adult women. Vaccine. 2011;29(32):5238–44.PubMedCentralPubMedCrossRef Manhart LE, Burgess-Hull AJ, Fleming CB, Bailey JA, Haggerty KP, Catalano RF. HPV vaccination among a community sample of young adult women. Vaccine. 2011;29(32):5238–44.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat (CDC) CfDCaP. National and state vaccination coverage among adolescents aged 13 through 17 years–United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117–23. (CDC) CfDCaP. National and state vaccination coverage among adolescents aged 13 through 17 years–United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117–23.
17.
Zurück zum Zitat Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93.PubMedCrossRef Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93.PubMedCrossRef
18.
Zurück zum Zitat Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188–94.PubMedCrossRef Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188–94.PubMedCrossRef
19.
Zurück zum Zitat Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis. 2007;34(7):468–71.PubMed Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis. 2007;34(7):468–71.PubMed
20.
Zurück zum Zitat Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58(7):1405–13.PubMedCrossRef Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58(7):1405–13.PubMedCrossRef
22.
Zurück zum Zitat Kobetz E, Kornfeld J, Vanderpool RC, Finney Rutten LJ, Parekh N, O’Bryan G, et al. Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010;15(Suppl 3):22–9.PubMedCrossRef Kobetz E, Kornfeld J, Vanderpool RC, Finney Rutten LJ, Parekh N, O’Bryan G, et al. Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010;15(Suppl 3):22–9.PubMedCrossRef
23.
Zurück zum Zitat Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108–15.PubMedCrossRef Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108–15.PubMedCrossRef
24.
Zurück zum Zitat Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439–45.PubMedCrossRef Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439–45.PubMedCrossRef
25.
Zurück zum Zitat Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Womens Health (Larchmt). 2009;18(11):1793–9.CrossRef Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Womens Health (Larchmt). 2009;18(11):1793–9.CrossRef
26.
Zurück zum Zitat Waller PR, Crow C, Sands D, Becker H. Health related attitudes and health promoting behaviors: differences between health fair attenders and a community group. Am J Health Promot. 1988;3(1):17–23, 32. Waller PR, Crow C, Sands D, Becker H. Health related attitudes and health promoting behaviors: differences between health fair attenders and a community group. Am J Health Promot. 1988;3(1):17–23, 32.
Metadaten
Titel
HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border
verfasst von
Jennifer Molokwu
Norma P. Fernandez
Charmaine Martin
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Journal of Immigrant and Minority Health / Ausgabe 3/2014
Print ISSN: 1557-1912
Elektronische ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-013-9855-z

Weitere Artikel der Ausgabe 3/2014

Journal of Immigrant and Minority Health 3/2014 Zur Ausgabe